This Project Grant award of $2,940,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Connecticut Health Center (UCHC) to transform care for extremity composite injuries through innovations in regenerative medicine and translational research. The award, which runs from November 1, 2024 to October 31, 2027, aims to advance medical solutions for the battlefield and improve healthcare for service members and...
The University of Connecticut received a $300,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 15, 2025, with a completion date of August 14, 2027, supports research aimed at "Enhancing Inflammation-Repressive Function of the Lupus Susceptibility Protein TNIP1". This project-based grant contributes to the program's broader objective of transforming healthcare for military...
This federal Project Grant award, with an obligated amount of $361,679.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will support research conducted by the University of Connecticut to develop dual-function biomaterials for the treatment of interstitial cystitis. The research aims to transform healthcare for military service members and the broader public by pursuing innovative solutions to critical medical...
The University of Connecticut Health Center (UCHC) received a $1,182,528 Project Grant award from the Defense Health Agency to develop a multifunctional bandage lens and bioadhesive for the treatment of corneal wounds. This award, which runs from September 1, 2023 to August 31, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420). The grant supports UCHC's research to transform health care for Service Members and the American public through innovative and...
This Project Grant award from the Defense Health Agency provides $2,999,990 to the University of Connecticut under the Military Medical Research and Development federal grant program (CFDA 12.420) from July 1, 2022 to June 30, 2026. The award will fund the OPTIMIZING CLINICAL OUTCOMES FOR PATIENTS WITH PATELLOFEMORAL PAIN USING STRENGTH TRAINING REHABILITATION INCORPORATING POWER EXERCISES (STRIPE) project. The University of Connecticut will lead a study to develop a strength training...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $435,465.00 to the University of Connecticut Health Center (UCHC) to conduct research on the use of acoustic radiation force and cell therapy to heal large-scale cranial defects. The project will run from February 1, 2025 to January 31, 2027. As part of this effort, UCHC will collaborate with the Connecticut Children's Medical Center, which will...
The U.S. Department of Defense's Military Medical Research and Development (CFDA 12.420) program awarded a $749,343 project grant to New York University (NYU) on August 1, 2025. The grant supports a 2-year research project titled "P15-1 PEPTIDE TREATMENT FOR CARTILAGE INJURIES AND POST-TRAUMATIC OSTEOARTHRITIS" to be completed by July 31, 2027. Through this funding, NYU will conduct advanced biomedical research to develop innovative treatments for cartilage injuries and...
This $298,329 federal Project Grant awarded by the Defense Health Agency on March 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Arkansas for Medical Sciences (UAMS) on the role of subchondral bone osteocytes in post-traumatic osteoarthritis. UAMS, a major academic medical center, will leverage its expertise in biomedical research to investigate this specific aspect of osteoarthritis development over the 2-year award...
The University of Connecticut (UConn) received a $19,605,709 Project Grant from the Department of the Navy's Basic and Applied Scientific Research program (CFDA 12.300) to conduct a wide range of research and development activities aimed at improving naval operations. The 4-year grant supports scientific studies, technology development, and training across diverse fields such as ocean sciences, materials science, electronics, autonomous systems, and directed energy. Key sub-awards to the...